Kahn Brothers Group IncNVS history

Issuer:
Novartis AG Sponsored ADR
Quarters tracked:
48 (Q2 2014Q1 2026)
Current shares:
13,386
Current value:
$2.04M
Peak shares:
30,968 (Q4 2014)
Overall change:
-49%
QuarterSharesValue$/ShareShare ΔΔ%
Q1 202613,386$2.04M$152.77-292-2%
Q4 202513,678$1.89M$137.89-648-5%
Q3 202514,326$1.84M$128.23-4,145-22%
Q2 202518,471$2.23M$121.00-3,438-16%
Q1 202521,909$2.44M$111.51+728+3%
Q4 202421,181$2.06M$97.30+3,600+20%
Q3 202417,581$2.02M$115.0100%
Q2 202417,581$1.87M$106.48+2,168+14%
Q1 202415,413$1.49M$96.74-2,650-15%
Q4 202318,063$1.82M$100.98-3,515-16%
Q3 202321,578$2.20M$101.8600%
Q2 202321,578$2.18M$100.8900%
Q1 202321,578$1.99M$91.9900%
Q4 202221,578$1.96M$90.74-1,500-6%
Q3 202223,078$1.75M$76.0000%
Q2 202223,078$1.95M$84.50+700+3%
Q1 202222,378$1.96M$87.7600%
Q4 202122,378$1.96M$87.45+1,980+10%
Q3 202120,398$1.67M$81.7700%
Q2 202120,398$1.86M$91.2300%
Q1 202120,398$1.74M$85.50-2,000-9%
Q4 202022,398$2.12M$94.43-300-1%
Q3 202022,698$1.97M$86.9700%
Q2 202022,698$1.98M$87.32-500-2%
Q1 202023,198$1.91M$82.46-2,575-10%
Q4 201925,773$2.44M$94.6700%
Q3 201925,773$2.24M$86.9100%
Q2 201925,773$2.35M$91.30+3,029+13%
Q1 201922,744$2.19M$96.1600%
Q4 201822,744$1.95M$85.82-466-2%
Q3 201823,210$2.00M$86.1700%
Q2 201823,210$1.75M$75.53+1,200+5%
Q1 201822,010$1.78M$80.87-4,600-17%
Q4 201726,610$2.23M$83.95+466+2%
Q3 201726,144$2.24M$85.83-670%
Q2 201726,211$2.19M$83.48-1,700-6%
Q1 201727,911$2.07M$74.27+840+3%
Q4 201627,071$1.97M$72.85-572-2%
Q3 201627,643$2.18M$78.9700%
Q2 201627,643$2.28M$82.5200%
Q1 201627,643$2.00M$72.4200%
Q4 201527,643$2.38M$86.03-900-3%
Q3 201528,543$2.62M$91.93+400+1%
Q2 201528,143$2.77M$98.35-2,825-9%
Q1 201530,968$3.05M$98.6200%
Q4 201430,968$2.87M$92.64+600+2%
Q3 201430,368$2.86M$94.15+4,000+15%
Q2 201426,368$2.39M$90.53NEW